{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:19:50Z","timestamp":1788740390598,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Circulatory osteocalcin (OC) has been widely used as a biomarker to indicate bone turnover status in postmenopausal osteoporosis (PMO). However, the change of serum OC (sOC) level in PMO cases compared to postmenopausal controls remains controversial.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched the online database of PubMed and Cochrane Library. A meta-analysis of case-control studies was performed to compare the pooled sOC level between PMO patients and postmenopausal controls. Subgroup analysis according to potential confounding factors (different OC molecules and regions of the study population) was also performed.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ten case-control studies with 1577 postmenopausal women were included in this meta analysis. We found no significant difference in the pooled sOC level [mean difference (MD)\u2009=\u20091.84, 95% confidence interval (CI): (\u2212\u20091.49, 5.16), <jats:italic>p<\/jats:italic>\u2009=\u20090.28] between PMO patients and controls. Subgroup analysis also revealed no significant difference in intact OC [MD\u2009=\u20091.76, 95%CI: (\u2212\u20091.71, 5.23), <jats:italic>p<\/jats:italic>\u2009=\u20090.32] or N-terminal mid-fragment of the OC molecule [MD\u2009=\u20090.67, 95%(\u2212\u20095.83, 7.18), <jats:italic>p<\/jats:italic>\u2009=\u20090.84] between groups. For different regions, no significant difference in sOC was found in Asian population between cases and controls [MD\u2009=\u2009-0.06, 95%(\u2212\u20096.02, 5.89), <jats:italic>p<\/jats:italic>\u2009=\u20090.98], while the pooled sOC level was significantly higher in European PMO cases than controls [MD\u2009=\u20093.15, 95%(0.90, 5.39), <jats:italic>p<\/jats:italic>\u2009=\u20090.006].<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our analysis revealed no significant difference in sOC level between PMO cases and controls according to all the current eligible studies. OC molecules are quite heterogeneous in the circulation and can be influenced by glucose metabolism. Therefore, sOC is currently not a good indicator for the high bone turnover status in PMO. More trials with standardized methodologies for the evaluation of circulatory OC are awaited to update our current findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-019-2863-y","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T17:02:41Z","timestamp":1573664561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A meta-analysis of serum osteocalcin level in postmenopausal osteoporotic women compared to controls"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhongyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"issue":"1","key":"2863_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):23\u201357.","journal-title":"Osteoporos Int"},{"key":"2863_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","volume":"6","author":"X Feng","year":"2011","unstructured":"Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol. 2011;6:121\u201345.","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"2863_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1055\/s-0034-1384629","volume":"32","author":"RD Jackson","year":"2014","unstructured":"Jackson RD, Mysiw WJ. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative. Semin Reprod Med. 2014;32(6):454\u201362.","journal-title":"Semin Reprod Med"},{"issue":"3","key":"2863_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","volume":"69","author":"PV Hauschka","year":"1989","unstructured":"Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev. 1989;69(3):990\u20131047.","journal-title":"Physiol Rev"},{"issue":"10","key":"2863_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3949\/ccjm.75.10.739","volume":"75","author":"FR Singer","year":"2008","unstructured":"Singer FR, Eyre DR. Using biochemical markers of bone turnover in clinical practice. Cleve Clin J Med. 2008;75(10):739\u201350.","journal-title":"Cleve Clin J Med"},{"issue":"18","key":"2863_CR6","doi-asserted-by":"publisher","first-page":"18361","DOI":"10.1074\/jbc.M314324200","volume":"279","author":"KK Ivaska","year":"2004","unstructured":"Ivaska KK, Hentunen TA, Vaaraniemi J, Ylipahkala H, Pettersson K, Vaananen HK. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem. 2004;279(18):18361\u20139.","journal-title":"J Biol Chem"},{"issue":"11","key":"2863_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18110","volume":"18","author":"J Burch","year":"2014","unstructured":"Burch J, Rice S, Yang H, Neilson A, Stirk L, Francis R, Holloway P, Selby P, Craig D. Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups. Health Technol Assess. 2014;18(11):1\u2013180.","journal-title":"Health Technol Assess"},{"issue":"3","key":"2863_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5535\/arm.2018.42.3.441","volume":"42","author":"SG Park","year":"2018","unstructured":"Park SG, Jeong SU, Lee JH, Ryu SH, Jeong HJ, Sim YJ, Kim DK, Kim GC. The changes of CTX, DPD, Osteocalcin, and bone mineral density during the postmenopausal period. Ann Rehabil Med. 2018;42(3):441\u20138.","journal-title":"Ann Rehabil Med"},{"key":"2863_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jtemb.2018.03.005","volume":"48","author":"O Boyacioglu","year":"2018","unstructured":"Boyacioglu O, Orenay-Boyacioglu S, Yildirim H, Korkmaz M. Boron intake, osteocalcin polymorphism and serum level in postmenopausal osteoporosis. J Trace Elem Med Biol. 2018;48:52\u20136.","journal-title":"J Trace Elem Med Biol"},{"issue":"4","key":"2863_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jbmr.5650050402","volume":"5","author":"EF Eriksen","year":"1990","unstructured":"Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res. 1990;5(4):311\u20139.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2863_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jbmr.5650110307","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11(3):337\u201349.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2863_CR12","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1172\/JCI27071","volume":"115","author":"LG Raisz","year":"2005","unstructured":"Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115(12):3318\u201325.","journal-title":"J Clin Invest"},{"issue":"1","key":"2863_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jbspin.2011.05.003","volume":"79","author":"E Biver","year":"2012","unstructured":"Biver E, Chopin F, Coiffier G, Brentano TF, Bouvard B, Garnero P, Cortet B. Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. Joint Bone Spine. 2012;79(1):20\u20135.","journal-title":"Joint Bone Spine"},{"issue":"12","key":"2863_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083138","volume":"8","author":"N Panic","year":"2013","unstructured":"Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One. 2013;8(12):e83138.","journal-title":"PLoS One"},{"issue":"5","key":"2863_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336\u201341.","journal-title":"Int J Surg"},{"issue":"6","key":"2863_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF01622200","volume":"4","author":"JA Kanis","year":"1994","unstructured":"Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368\u201381.","journal-title":"Osteoporos Int"},{"issue":"9","key":"2863_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"2863_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/jcp.2010.086595","volume":"64","author":"S Jabbar","year":"2011","unstructured":"Jabbar S, Drury J, Fordham JN, Datta HK, Francis RM, Tuck SP. Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. J Clin Pathol. 2011;64(4):354\u20137.","journal-title":"J Clin Pathol"},{"issue":"3","key":"2863_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00404-006-0148-9","volume":"274","author":"FF Verit","year":"2006","unstructured":"Verit FF, Geyikli I, Yazgan P, Celik A. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Arch Gynecol Obstet. 2006;274(3):133\u20137.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"2863_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00198-005-1954-9","volume":"17","author":"JM Pouilles","year":"2006","unstructured":"Pouilles JM, Tremollieres FA, Ribot C. Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics. Osteoporos Int. 2006;17(2):193\u2013200.","journal-title":"Osteoporos Int"},{"issue":"4","key":"2863_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00198-005-0017-6","volume":"17","author":"XH Luo","year":"2006","unstructured":"Luo XH, Guo LJ, Shan PF, Xie H, Wu XP, Zhang H, Cao XZ, Yuan LQ, Liao EY. Relationship of circulating MMP-2, MMP-1, and TIMP-1 levels with bone biochemical markers and bone mineral density in postmenopausal Chinese women. Osteoporos Int. 2006;17(4):521\u20136.","journal-title":"Osteoporos Int"},{"issue":"5","key":"2863_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000079524","volume":"13","author":"BS Duman","year":"2004","unstructured":"Duman BS, Tanakol R, Erensoy N, Ozturk M, Yilmazer S. Vitamin D receptor alleles, bone mineral density and turnover in postmenopausal osteoporotic and healthy women. Med Princ Pract. 2004;13(5):260\u20136.","journal-title":"Med Princ Pract"},{"issue":"2","key":"2863_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF02672511","volume":"8","author":"CC Dominguez","year":"1998","unstructured":"Dominguez CC, Sosa HM, Traba ML, Alvarez VE, de la Piedra C. Biochemical markers of bone formation in the study of postmenopausal osteoporosis. Osteoporos Int. 1998;8(2):147\u201351.","journal-title":"Osteoporos Int"},{"issue":"5","key":"2863_CR24","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0002-9378(96)70598-7","volume":"174","author":"JG Kim","year":"1996","unstructured":"Kim JG, Lee JY. Serum insulin-like growth factor binding protein profiles in postmenopausal women: their correlation with bone mineral density. Am J Obstet Gynecol. 1996;174(5):1511\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2863_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-2007-979928","volume":"27","author":"DE Diaz","year":"1995","unstructured":"Diaz DE, Diaz MM, de la Piedra C, Rapado A. Lack of correlation between levels of osteocalcin and bone alkaline phosphatase in healthy control and postmenopausal osteoporotic women. Horm Metab Res. 1995;27(3):151\u20134.","journal-title":"Horm Metab Res"},{"issue":"9","key":"2863_CR26","first-page":"16352","volume":"8","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Feng E, Xu Y, Wang W, Zhang T, Xiao L, Chen R, Lin Y, Chen D, Lin L, et al. Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Int J Clin Exp Med. 2015;8(9):16352\u20137.","journal-title":"Int J Clin Exp Med"},{"issue":"9","key":"2863_CR27","first-page":"2812","volume":"7","author":"NM Al-Daghri","year":"2014","unstructured":"Al-Daghri NM, Yakout S, Al-Shehri E, Al-Fawaz H, Aljohani N, Al-Saleh Y. Inflammatory and bone turnover markers in relation to PTH and vitamin D status among Saudi postmenopausal women with and without osteoporosis. Int J Clin Exp Med. 2014;7(9):2812\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"2863_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11914-015-0267-y","volume":"13","author":"J Wei","year":"2015","unstructured":"Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Curr Osteoporos Rep. 2015;13(3):180\u20135.","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"2863_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142(2):296\u2013308.","journal-title":"Cell"},{"issue":"6","key":"2863_CR30","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1172\/JCI65952","volume":"123","author":"F Oury","year":"2013","unstructured":"Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J, Srinivas P, Chamouni A, Lugani F, Lejeune H, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest. 2013;123(6):2421\u201333.","journal-title":"J Clin Invest"},{"key":"2863_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06360.x","volume":"1260","author":"F Oury","year":"2012","unstructured":"Oury F. A crosstalk between bone and gonads. Ann N Y Acad Sci. 2012;1260:1\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"2863_CR32","first-page":"9892048","volume":"2017","author":"ZY Liu","year":"2017","unstructured":"Liu ZY, Yang Y, Wen CY, Rong LM. Serum Osteocalcin and testosterone concentrations in adult males with or without primary osteoporosis: a Meta-analysis. Biomed Res Int. 2017;2017:9892048.","journal-title":"Biomed Res Int"},{"issue":"Pt 4","key":"2863_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/000456320003700402","volume":"37","author":"AJ Lee","year":"2000","unstructured":"Lee AJ, Hodges S, Eastell R. Measurement of osteocalcin. Ann Clin Biochem. 2000;37(Pt 4):432\u201346.","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"2863_CR34","first-page":"333","volume":"17","author":"MS Calvo","year":"1996","unstructured":"Calvo MS, Eyre DR, Gundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev. 1996;17(4):333\u201368.","journal-title":"Endocr Rev"},{"issue":"5","key":"2863_CR35","first-page":"285","volume":"42","author":"P Coates","year":"2013","unstructured":"Coates P. Bone turnover markers. Aust Fam Physician. 2013;42(5):285\u20137.","journal-title":"Aust Fam Physician"},{"issue":"2","key":"2863_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/jbmr.5650090215","volume":"9","author":"P Garnero","year":"1994","unstructured":"Garnero P, Grimaux M, Seguin P, Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res. 1994;9(2):255\u201364.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2863_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrendo.2012.201","volume":"9","author":"SL Booth","year":"2013","unstructured":"Booth SL, Centi A, Smith SR, Gundberg C. The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol. 2013;9(1):43\u201355.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"2863_CR38","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s00198-015-3197-8","volume":"26","author":"DM Liu","year":"2015","unstructured":"Liu DM, Guo XZ, Tong HJ, Tao B, Sun LH, Zhao HY, Ning G, Liu JM. Association between osteocalcin and glucose metabolism: a meta-analysis. Osteoporos Int. 2015;26(12):2823\u201333.","journal-title":"Osteoporos Int"},{"issue":"5","key":"2863_CR39","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3892\/etm.2017.4206","volume":"13","author":"Y Suzuki","year":"2017","unstructured":"Suzuki Y, Maruyama-Nagao A, Sakuraba K, Kawai S. Level of serum undercarboxylated osteocalcin correlates with bone quality assessed by calcaneal quantitative ultrasound sonometry in young Japanese females. Exp Ther Med. 2017;13(5):1937\u201343.","journal-title":"Exp Ther Med"},{"issue":"5\u20136","key":"2863_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000452130","volume":"9","author":"XY Zhang","year":"2016","unstructured":"Zhang XY, He JW, Fu WZ, Liu YJ, Zhang ZL. Associations of serum Osteocalcin and polymorphisms of the Osteocalcin gene with bone mineral density in postmenopausal and elderly Chinese women. J Nutrigenet Nutrigenomics. 2016;9(5\u20136):231\u201342.","journal-title":"J Nutrigenet Nutrigenomics"},{"issue":"3","key":"2863_CR41","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00198-014-2954-4","volume":"26","author":"Y Nagata","year":"2015","unstructured":"Nagata Y, Inaba M, Imanishi Y, Okazaki H, Yamada S, Mori K, Shoji S, Koyama H, Okuno S. Increased undercarboxylated osteocalcin\/intact osteocalcin ratio in patients undergoing hemodialysis. Osteoporos Int. 2015;26(3):1053\u201361.","journal-title":"Osteoporos Int"},{"issue":"2","key":"2863_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3945\/an.112.001834","volume":"3","author":"CM Gundberg","year":"2012","unstructured":"Gundberg CM, Lian JB, Booth SL. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Advances in nutrition (Bethesda, Md). 2012;3(2):149\u201357.","journal-title":"Advances in nutrition (Bethesda, Md)"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2863-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-019-2863-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2863-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:12:11Z","timestamp":1605139931000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-019-2863-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2863"],"URL":"https:\/\/doi.org\/10.1186\/s12891-019-2863-y","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]},"assertion":[{"value":"5 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"532"}}